首页 > 最新文献

Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians最新文献

英文 中文
Emergency departments and abuse: policy issues, practice barriers, and recommendations. 急诊科和滥用:政策问题、实践障碍和建议。
C T Conti

The abuse of women has reached epidemic proportions. There are an estimated 12 million abused women in the United States. Reported cases of abuse, however, range from 2 to 4 million. Less than 15% of these women ever seek medical care. Of women who do seek care, an estimated 75% use the emergency department, often presenting with complaints not readily suggestive of abuse. Reports indicate, however, that emergency departments consistently identify less than 10% of all abuse cases. In 1991 and 1992, the Joint Commission on Accreditation of Healthcare Organizations established standards for emergency departments to develop policies and procedures for the identification, treatment, and referral of female and elderly victims of abuse. Virtually all emergency medicine professional societies have official policies to encourage development of protocols for abuse identification and management. The American Medical Association and the Department of Health and Human Services have likewise developed guidelines to help emergency departments achieve these national health care objectives. Currently, less than 50% of all emergency departments have established algorithms to address abused women who present to the emergency department for treatment. This article reviews current health policy, examines the impediments to the detection of abuse in the emergency department, and recommends mechanisms to enhance the awareness of abuse among emergency department personnel.

对妇女的虐待已达到流行病的程度。据估计,美国有1200万受虐妇女。然而,报告的虐待案件从200万到400万不等。这些妇女中只有不到15%的人寻求过医疗护理。在寻求治疗的女性中,估计有75%的人去了急诊科,她们的抱怨往往不容易让人联想到虐待。然而,报告表明,在所有虐待案件中,急诊科始终发现的不到10%。1991年和1992年,保健组织认证联合委员会为急诊科制定了标准,以制定识别、治疗和转诊受虐待的妇女和老年人受害者的政策和程序。几乎所有急诊医学专业协会都制定了官方政策,鼓励制定识别和管理滥用行为的规程。美国医学协会和卫生与公众服务部同样制定了指导方针,以帮助急诊科实现这些国家卫生保健目标。目前,在所有急诊科中,只有不到50%的急诊科建立了处理到急诊科就诊的受虐待妇女的程序。本文回顾了当前的卫生政策,研究了在急诊科发现虐待行为的障碍,并建议了提高急诊科人员对虐待行为认识的机制。
{"title":"Emergency departments and abuse: policy issues, practice barriers, and recommendations.","authors":"C T Conti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The abuse of women has reached epidemic proportions. There are an estimated 12 million abused women in the United States. Reported cases of abuse, however, range from 2 to 4 million. Less than 15% of these women ever seek medical care. Of women who do seek care, an estimated 75% use the emergency department, often presenting with complaints not readily suggestive of abuse. Reports indicate, however, that emergency departments consistently identify less than 10% of all abuse cases. In 1991 and 1992, the Joint Commission on Accreditation of Healthcare Organizations established standards for emergency departments to develop policies and procedures for the identification, treatment, and referral of female and elderly victims of abuse. Virtually all emergency medicine professional societies have official policies to encourage development of protocols for abuse identification and management. The American Medical Association and the Department of Health and Human Services have likewise developed guidelines to help emergency departments achieve these national health care objectives. Currently, less than 50% of all emergency departments have established algorithms to address abused women who present to the emergency department for treatment. This article reviews current health policy, examines the impediments to the detection of abuse in the emergency department, and recommends mechanisms to enhance the awareness of abuse among emergency department personnel.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20566147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition assessment in children with sickle cell disease. 镰状细胞病儿童的营养评估
R Williams, E O George, W Wang

Children with sickle cell disease have decreased height and weight when compared with their peers. Although exact reasons for poor growth have not been established, increased calorie and protein needs and deficiencies in zinc, folic acid, and vitamins A, C, and E may be factors. To determine whether inadequate nutrient intake contributes to this poor growth, we conducted a survey of the nutrition knowledge and practices of families affected by sickle cell disease. Sixty-one patients with a median age of 8 years (range, 13 months to 17 years) participated in the study. Patients with homozygous S hemoglobin (sickle cell) disease (Hb SS, n = 34) and sickle beta zero thalassemia (Hb S beta zero-thalassemia, n = 2) were combined; 19% were below the fifth percentile for height. The other patients, with sickle hemoglobin C disease (Hb SC, n = 21) and sickle beta plus thalassemia (Hb beta(+)-thalassemia, n = 4), were grouped, and 4% were below the fifth percentile for height (P = .043). Ninety percent of the study patients or their parents were familiar with the food groups indicated on the US Department of Agriculture's Food Guide Pyramid, but most patients failed to consume appropriate amounts from those groups. Although two thirds of the patients ate the recommended number of servings daily from the meat group, only 20% to 31% of the recommended servings from each of the other food groups was consumed. This was possibly related to low socioeconomic status. The patients in the Hb SS group ate significantly less from the bread (P < .037) and milk (P < .022) categories than the patients in the Hb SC group. Fifty-nine percent of families had incomes below the poverty level, and 79% participated in a food assistance program. We conclude that the nutrient intake of patients with sickle cell disease is often inadequate. Education for patients with sickle cell disease should focus on (1) specific nutrient needs, with proper distribution of dietary intake among the food groups, (2) ways to provide nutritious meals on a limited income, and (3) methods for increasing calorie and protein intake.

与同龄人相比,患有镰状细胞病的儿童身高和体重都有所下降。虽然发育不良的确切原因尚未确定,但增加的卡路里和蛋白质需求以及锌、叶酸和维生素A、C和E的缺乏可能是因素。为了确定营养摄入不足是否导致这种生长不良,我们对镰状细胞病家庭的营养知识和实践进行了调查。61例患者中位年龄为8岁(范围13个月至17岁)参加了这项研究。合并纯合子S血红蛋白(镰状细胞)病(Hb SS, n = 34)和镰状β零型地中海贫血(Hb S β零型地中海贫血,n = 2)患者;19%的人身高低于第五个百分位数。其他镰状血红蛋白C病(Hb SC, n = 21)和镰状β +地中海贫血(Hb β(+)-地中海贫血,n = 4)患者分组,4%的患者身高低于第5百分位(P = 0.043)。90%的研究患者或他们的父母都熟悉美国农业部食物指南金字塔上列出的食物类别,但大多数患者未能从这些类别中摄入适量的食物。虽然三分之二的患者每天食用推荐数量的肉类,但只有20%到31%的其他食物被食用。这可能与低社会经济地位有关。与Hb SC组相比,Hb SS组患者食用面包(P < 0.037)和牛奶(P < 0.022)的数量明显减少。59%的家庭收入低于贫困水平,79%的家庭参加了食品援助计划。我们得出结论,镰状细胞病患者的营养摄入往往不足。对镰状细胞病患者的教育应侧重于(1)特定的营养需求,合理分配膳食摄入量,(2)如何在有限的收入下提供营养膳食,(3)增加热量和蛋白质摄入量的方法。
{"title":"Nutrition assessment in children with sickle cell disease.","authors":"R Williams,&nbsp;E O George,&nbsp;W Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Children with sickle cell disease have decreased height and weight when compared with their peers. Although exact reasons for poor growth have not been established, increased calorie and protein needs and deficiencies in zinc, folic acid, and vitamins A, C, and E may be factors. To determine whether inadequate nutrient intake contributes to this poor growth, we conducted a survey of the nutrition knowledge and practices of families affected by sickle cell disease. Sixty-one patients with a median age of 8 years (range, 13 months to 17 years) participated in the study. Patients with homozygous S hemoglobin (sickle cell) disease (Hb SS, n = 34) and sickle beta zero thalassemia (Hb S beta zero-thalassemia, n = 2) were combined; 19% were below the fifth percentile for height. The other patients, with sickle hemoglobin C disease (Hb SC, n = 21) and sickle beta plus thalassemia (Hb beta(+)-thalassemia, n = 4), were grouped, and 4% were below the fifth percentile for height (P = .043). Ninety percent of the study patients or their parents were familiar with the food groups indicated on the US Department of Agriculture's Food Guide Pyramid, but most patients failed to consume appropriate amounts from those groups. Although two thirds of the patients ate the recommended number of servings daily from the meat group, only 20% to 31% of the recommended servings from each of the other food groups was consumed. This was possibly related to low socioeconomic status. The patients in the Hb SS group ate significantly less from the bread (P < .037) and milk (P < .022) categories than the patients in the Hb SC group. Fifty-nine percent of families had incomes below the poverty level, and 79% participated in a food assistance program. We conclude that the nutrient intake of patients with sickle cell disease is often inadequate. Education for patients with sickle cell disease should focus on (1) specific nutrient needs, with proper distribution of dietary intake among the food groups, (2) ways to provide nutritious meals on a limited income, and (3) methods for increasing calorie and protein intake.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20213043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Childhood mania: insights into diagnostic and treatment issues. 儿童躁狂症:诊断和治疗问题的见解。
J Wozniak, J Biederman

Our study's objective was to clarify the nosologic status of children who satisfy diagnostic criteria for bipolar disorder. Using blind raters and structured psychiatric interviews as well as data from other instruments, we undertook studies from various vantage points, examining children with bipolar disorder to confirm the existence of the diagnosis in children and to clarify its clinical course and characteristics. We found that (1) bipolar disorder in children referred to our clinical center is not as rare as previously thought; (2) bipolar disorder in children commonly presents with attention-deficit hyperactivity disorder, which makes diagnosis difficult; and (3) bipolar disorder in children presents with a clinical picture considered atypical by adult standards, with irritability, chronicity, and symptoms of mania mixed with those of depression. Our data suggest that childhood bipolar disorder is more common than previously thought, but it may be difficult to diagnose because of comorbidity with attention-deficit hyperactivity disorder and a developmentally different presentation from adults.

我们研究的目的是阐明满足双相情感障碍诊断标准的儿童的病理性状况。使用盲评者和结构化的精神病学访谈以及来自其他工具的数据,我们从不同的角度进行了研究,检查了患有双相情感障碍的儿童,以确认儿童诊断的存在,并阐明其临床过程和特征。我们发现(1)到我们临床中心就诊的儿童双相情感障碍并不像以前认为的那样罕见;(2)儿童双相情感障碍多表现为注意缺陷多动障碍,诊断困难;(3)儿童双相情感障碍的临床表现以成人标准来看是非典型的,具有易怒、慢性和躁狂症混合抑郁症状。我们的数据表明,儿童双相情感障碍比以前认为的更常见,但可能很难诊断,因为它与注意力缺陷多动障碍共病,并且与成人的发育表现不同。
{"title":"Childhood mania: insights into diagnostic and treatment issues.","authors":"J Wozniak,&nbsp;J Biederman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Our study's objective was to clarify the nosologic status of children who satisfy diagnostic criteria for bipolar disorder. Using blind raters and structured psychiatric interviews as well as data from other instruments, we undertook studies from various vantage points, examining children with bipolar disorder to confirm the existence of the diagnosis in children and to clarify its clinical course and characteristics. We found that (1) bipolar disorder in children referred to our clinical center is not as rare as previously thought; (2) bipolar disorder in children commonly presents with attention-deficit hyperactivity disorder, which makes diagnosis difficult; and (3) bipolar disorder in children presents with a clinical picture considered atypical by adult standards, with irritability, chronicity, and symptoms of mania mixed with those of depression. Our data suggest that childhood bipolar disorder is more common than previously thought, but it may be difficult to diagnose because of comorbidity with attention-deficit hyperactivity disorder and a developmentally different presentation from adults.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20420586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of breast screening outcomes from a cancer control intervention for African-American and white women in western New York. 纽约州西部非裔美国人和白人妇女癌症控制干预措施的乳腺筛查结果比较。
N L Roberson

This study's purpose was to compare breast screening outcomes, health practices, and risk factors for low-income African-American and white women who participated in a multistrategy cancer control intervention. Subjects were recruited from their communities to participate in breast screening activities (clinical breast examination and mammography testing). Data were collected via a screening intake form for a 2-year period (mid- 1994 to mid- 1996). As a result of the recruitment. 1444 women enrolled for breast screening services. They included 282 African Americans. 1079 whites, and 83 other minorities. African-American and white women alike reported deficiencies in monthly breast self-examination practices and previous mammography use. However, more African-American women than white women reported monthly breast self-examination practice (P < 001). More white than African-American women reported having had a previous mammogram (P < .002). Examination of selected risk factors showed that both African-American women and white women had minimum family history. A comparison of breast screening outcomes showed that African-American women presented with slightly more abnormalities than did white women after undergoing clinical breast exams and mammography. However, no significant difference was found when comparing these variables. Overall, African-American women were as likely as white women to participate in screening activities. There was little difference between these groups when comparing screening outcomes, health practices, and risk factors.

本研究的目的是比较参与多部门癌症控制干预的低收入非裔美国妇女和白人妇女的乳腺筛查结果、健康实践和风险因素。研究对象从其所在社区招募,参加乳房筛查活动(临床乳房检查和乳房 X 线照相术检测)。数据通过筛查接收表收集,为期两年(1994 年年中至 1996 年年中)。招募的结果是1444 名妇女参加了乳房筛查服务。其中包括 282 名非洲裔美国人。1079 名白人和 83 名其他少数族裔。非裔美国妇女和白人妇女都报告了每月乳房自我检查和以前使用乳房 X 射线照相术的不足之处。然而,报告每月进行乳房自我检查的非裔美国妇女多于白人妇女(P < 001)。与非裔美国妇女相比,有更多的白人妇女表示曾接受过乳房 X 光检查(P < .002)。对选定风险因素的研究表明,非裔美国妇女和白人妇女的家族史都很少。对乳房筛查结果的比较显示,非裔美国妇女在接受临床乳房检查和乳房 X 光检查后,出现的异常情况略多于白人妇女。然而,在比较这些变量时并未发现明显差异。总体而言,非裔美国妇女与白人妇女一样有可能参加筛查活动。在比较筛查结果、健康实践和风险因素时,这些群体之间的差异不大。
{"title":"Comparison of breast screening outcomes from a cancer control intervention for African-American and white women in western New York.","authors":"N L Roberson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study's purpose was to compare breast screening outcomes, health practices, and risk factors for low-income African-American and white women who participated in a multistrategy cancer control intervention. Subjects were recruited from their communities to participate in breast screening activities (clinical breast examination and mammography testing). Data were collected via a screening intake form for a 2-year period (mid- 1994 to mid- 1996). As a result of the recruitment. 1444 women enrolled for breast screening services. They included 282 African Americans. 1079 whites, and 83 other minorities. African-American and white women alike reported deficiencies in monthly breast self-examination practices and previous mammography use. However, more African-American women than white women reported monthly breast self-examination practice (P < 001). More white than African-American women reported having had a previous mammogram (P < .002). Examination of selected risk factors showed that both African-American women and white women had minimum family history. A comparison of breast screening outcomes showed that African-American women presented with slightly more abnormalities than did white women after undergoing clinical breast exams and mammography. However, no significant difference was found when comparing these variables. Overall, African-American women were as likely as white women to participate in screening activities. There was little difference between these groups when comparing screening outcomes, health practices, and risk factors.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20114375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mental health issues of culturally diverse underserved children. 不同文化的弱势儿童的心理健康问题。
I A Canino, J Spurlock

This article addresses the clinical issues relevant to mental health workers when evaluating children of diverse cultures who live in conditions of persistent poverty. We suggest a model that considers the social as well as the biologic risk factors affecting these children and that includes the importance of culture on symptom expression and health-seeking behavior. The discussion includes specific assessment approaches sensitive to the context in which these children develop and the psychiatric diagnostic entities and treatment approaches thought to be particularly relevant to these children.

这篇文章解决了心理健康工作者在评估生活在持续贫困条件下的不同文化的儿童时相关的临床问题。我们建议建立一个模型,考虑影响这些儿童的社会和生物风险因素,并包括文化对症状表达和寻求健康行为的重要性。讨论包括对这些儿童发展的环境敏感的具体评估方法,以及被认为与这些儿童特别相关的精神诊断实体和治疗方法。
{"title":"Mental health issues of culturally diverse underserved children.","authors":"I A Canino,&nbsp;J Spurlock","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This article addresses the clinical issues relevant to mental health workers when evaluating children of diverse cultures who live in conditions of persistent poverty. We suggest a model that considers the social as well as the biologic risk factors affecting these children and that includes the importance of culture on symptom expression and health-seeking behavior. The discussion includes specific assessment approaches sensitive to the context in which these children develop and the psychiatric diagnostic entities and treatment approaches thought to be particularly relevant to these children.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20420583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Massive nerve root hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy. 慢性炎症性脱髓鞘性多根神经病变的大量神经根肥大。
M M Kitakule, A McNeal

In the course of investigating severe, shooting leg pains in a patient with chronic inflammatory demyelinating polyradiculoneuropathy, we observed massive nerve root enlargement on magnetic resonance imaging. Clinical evaluation ruled out other possible etiologies. Lumbar laminectomy was performed in an attempt to alleviate the pain, with poor results. A review of the literature revealed that seven similar cases have been reported in the past. We report another case and a review of the literature.

在研究慢性炎症性脱髓鞘性多根神经病变患者的严重射腿痛的过程中,我们在磁共振成像上观察到大量的神经根扩大。临床评估排除了其他可能的病因。腰椎椎板切除术试图减轻疼痛,但效果不佳。文献回顾显示,过去曾报道过7例类似病例。我们报告另一个病例并复习文献。
{"title":"Massive nerve root hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy.","authors":"M M Kitakule,&nbsp;A McNeal","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the course of investigating severe, shooting leg pains in a patient with chronic inflammatory demyelinating polyradiculoneuropathy, we observed massive nerve root enlargement on magnetic resonance imaging. Clinical evaluation ruled out other possible etiologies. Lumbar laminectomy was performed in an attempt to alleviate the pain, with poor results. A review of the literature revealed that seven similar cases have been reported in the past. We report another case and a review of the literature.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20212315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overt malignancy in long-term hemodialysis patients. 长期血液透析患者的明显恶性肿瘤。
O Ifudu, L J Macey, E A Friedman

We studied all 39 patients who were on maintenance hemodialysis for 10 years or more (range, 10 to 24 years) in three free-standing, not-for-profit hemodialysis units to determine the prevalence of malignancy. The three dialysis units have a total patient population of 470, all of whom are cared for by the same group of physicians. From the same dialysis units, we selected a control cohort of 37 patients matched for age, gender, race, and renal diagnosis who were on hemodialysis for 3 years or less (short-term patients). Control patients were selected by randomly choosing the next patient who filled the criteria for duration of dialysis from the roster of all patients at a facility. Clinically overt malignancy during dialytic therapy was determined by history, physical examination, Pap smear, mammogram, and colonoscopy in patients with gastrointestinal bleeding. The mean age (+/-SE) of the long-term patients was 51.8 +/- 1.9 years, and that of the control group was 51.5 +/- 2.4 years (P = .92). Thrice-weekly hemodialysis prescriptions were similar in both groups: long term, 3.5 +/- 0.02 hours; control, 3.4 +/- 0.02 hours (P = .27). No malignancy was detected in either the long-term or the short-term patients, and no patient of either group had a malignancy in the past. Colonic biopsy specimens of four long-term patients who had gastrointestinal bleeding were normal. The prevalence of malignancy was not increased in patients who were on maintenance hemodialysis for 10 years or longer.

我们研究了所有39名在三个独立的非营利性血液透析单位进行维持性血液透析10年或以上(范围,10至24年)的患者,以确定恶性肿瘤的患病率。这三个透析单位共有470名患者,所有患者都由同一组医生护理。从相同的透析单元中,我们选择了37名年龄、性别、种族和肾脏诊断相匹配的患者作为对照队列,这些患者接受血液透析3年或更短时间(短期患者)。对照患者是通过从一个机构的所有患者名册中随机选择下一个符合透析持续时间标准的患者来选择的。通过病史、体格检查、巴氏涂片、乳房x光检查和胃肠道出血患者结肠镜检查确定透析治疗期间临床明显的恶性肿瘤。长期组患者平均年龄(+/- se)为51.8 +/- 1.9岁,对照组平均年龄(+/- se)为51.5 +/- 2.4岁(P = 0.92)。两组每周三次血液透析处方相似:长期,3.5±0.02小时;对照组,3.4±0.02小时(P = 0.27)。长期和短期患者均未发现恶性肿瘤,两组患者既往均未发生恶性肿瘤。4例长期消化道出血患者结肠活检标本均正常。维持血液透析10年或更长时间的患者中,恶性肿瘤的患病率没有增加。
{"title":"Overt malignancy in long-term hemodialysis patients.","authors":"O Ifudu,&nbsp;L J Macey,&nbsp;E A Friedman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We studied all 39 patients who were on maintenance hemodialysis for 10 years or more (range, 10 to 24 years) in three free-standing, not-for-profit hemodialysis units to determine the prevalence of malignancy. The three dialysis units have a total patient population of 470, all of whom are cared for by the same group of physicians. From the same dialysis units, we selected a control cohort of 37 patients matched for age, gender, race, and renal diagnosis who were on hemodialysis for 3 years or less (short-term patients). Control patients were selected by randomly choosing the next patient who filled the criteria for duration of dialysis from the roster of all patients at a facility. Clinically overt malignancy during dialytic therapy was determined by history, physical examination, Pap smear, mammogram, and colonoscopy in patients with gastrointestinal bleeding. The mean age (+/-SE) of the long-term patients was 51.8 +/- 1.9 years, and that of the control group was 51.5 +/- 2.4 years (P = .92). Thrice-weekly hemodialysis prescriptions were similar in both groups: long term, 3.5 +/- 0.02 hours; control, 3.4 +/- 0.02 hours (P = .27). No malignancy was detected in either the long-term or the short-term patients, and no patient of either group had a malignancy in the past. Colonic biopsy specimens of four long-term patients who had gastrointestinal bleeding were normal. The prevalence of malignancy was not increased in patients who were on maintenance hemodialysis for 10 years or longer.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20213044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review of screening and early detection of endometrial cancer and use of risk assessment. 子宫内膜癌的筛查和早期检测及风险评估的应用综述。
S E Brooks

Although the majority of patients with endometrial cancer have a good prognosis, subgroups of individuals are at risk of more aggressive disease. Early detection programs should target individuals who have the highest risk of advanced disease, high-risk histology, and poorly differentiated tumors. This will afford the greatest improvement in survival. Screening of the general population is not cost-effective and indeed may incur iatrogenic morbidity. Recent data also suggest that routine screening of patients receiving tamoxifen citrate may not be indicated. This area is still being investigated. While screening is not appropriate for the general population, a strategy of early evaluation of postmenopausal bleeding with judicious use of endometrial biopsy is important for the early detection of endometrial cancer. Ultrasound is most effective in excluding pathology in symptomatic patients whose biopsy specimen is nondiagnostic. Fractional dilation and curettage is reserved for patients with abnormal vaginal bleeding who cannot undergo office biopsy or who experience persistent symptoms.

虽然大多数子宫内膜癌患者预后良好,但个体亚群有更严重疾病的风险。早期检测计划应该针对那些有最高风险的晚期疾病、高风险组织学和低分化肿瘤的个体。这将极大地提高生存率。对普通人群进行筛查并不具有成本效益,而且确实可能导致医源性发病率。最近的数据也表明,接受柠檬酸他莫昔芬治疗的患者可能不需要进行常规筛查。这一地区仍在调查中。虽然筛查不适合一般人群,但早期评估绝经后出血并明智地使用子宫内膜活检的策略对于早期发现子宫内膜癌是重要的。超声是最有效的排除病理在有症状的患者活检标本是非诊断。部分扩张和刮除是为阴道异常出血的患者保留的,这些患者不能进行办公室活检或经历持续的症状。
{"title":"A review of screening and early detection of endometrial cancer and use of risk assessment.","authors":"S E Brooks","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although the majority of patients with endometrial cancer have a good prognosis, subgroups of individuals are at risk of more aggressive disease. Early detection programs should target individuals who have the highest risk of advanced disease, high-risk histology, and poorly differentiated tumors. This will afford the greatest improvement in survival. Screening of the general population is not cost-effective and indeed may incur iatrogenic morbidity. Recent data also suggest that routine screening of patients receiving tamoxifen citrate may not be indicated. This area is still being investigated. While screening is not appropriate for the general population, a strategy of early evaluation of postmenopausal bleeding with judicious use of endometrial biopsy is important for the early detection of endometrial cancer. Ultrasound is most effective in excluding pathology in symptomatic patients whose biopsy specimen is nondiagnostic. Fractional dilation and curettage is reserved for patients with abnormal vaginal bleeding who cannot undergo office biopsy or who experience persistent symptoms.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20114374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased risk in esophageal obstruction with slow-release medications. 缓释药物增加食道梗阻的风险。
V Simko, D Joseph, S Michael

Although medication-induced (pill) esophagitis has been recognized for a long time, little data are available on the risk of recently introduced slow-release medications. These formulations may have an obstructive capability (undissolved medication blocking an obstructed lumen) or may cause tissue irritation (continuous leakage from a slowly disintegrating pill). We observed a patient with esophageal carcinoma who developed complete obstruction when three Procardia XL (nifedipine) extended-release tablets blocked the narrowed lumen. An intact Procardia XL tablet and a washed shell as a control were implanted subcutaneously in a rat. The intact pill produced a large inflammatory mass: in contrast, no inflammatory response was noted at the control site implanted with a washed shell. In vitro testing of seven different slow-release medications revealed a wide difference in their solubility at a neutral pH and in gastric juice of pH 1.8 (simulation of esophageal or gastric environment). Theolair-SR (anhydrous theophylline, sustained-release) tablets had the highest obstructive, but no irritating potential. Cardizem SR (diltiazem hydrochloride) sustained-release capsules dissolved promptly without obstructive potential. Adalat CC (nifedipine) extended-release tablets also dissolved early at both pH values. Cardizem CD (diltiazem hydrochloride) extended-release capsules and Calan SR (verapamil hydrochloride) sustained-release oral caplets disintegrated into granules that had a low obstructive potential, but their prolonged presence increased the risk of tissue irritation. Ecotrin (enteric-coated aspirin) tablets had a high obstructive and no irritating potential in the first 24 hours, after which they disintegrated and directly contacted the tissue. Procardia XL extended-release tablets had an insoluble shell that continued to leak a tissue-irritating content even after 48 hours, generating a prolonged obstructive and irritating condition. In conclusion, slow-release medications greatly increase the risk of esophageal injury. Their obstructive and tissue-irritating potentials differ widely. Slow-release formulations should be contraindicated in patients who have obstructive esophageal and gastric disorders.

虽然药物引起的(药片)食管炎很早以前就被认识到,但关于最近引入的缓释药物的风险的数据很少。这些制剂可能具有阻塞功能(未溶解的药物阻塞阻塞的管腔)或可能引起组织刺激(缓慢崩解的药丸持续泄漏)。我们观察了一位食管癌患者,当三片硝苯地平缓释片阻断狭窄的管腔后,患者发生完全梗阻。一个完整的普卡地亚XL片和一个洗净的壳作为对照植入大鼠皮下。完整的药丸产生了一个大的炎症团块;相比之下,在植入洗过的贝壳的对照部位没有发现炎症反应。7种不同缓释药物的体外测试显示,它们在中性pH和pH 1.8(模拟食管或胃环境)胃液中的溶解度存在很大差异。无水茶碱缓释片(Theolair-SR)具有最高的阻滞电位,但无刺激电位。Cardizem SR(盐酸地尔硫卓)缓释胶囊溶解迅速,无梗阻电位。阿达拉特CC(硝苯地平)缓释片在两种pH值下均提前溶解。Cardizem CD(盐酸地尔硫卓)缓释胶囊和Calan SR(盐酸维拉帕米)口服缓释胶囊崩解成颗粒,具有低阻塞电位,但它们的长期存在增加了组织刺激的风险。Ecotrin(肠溶膜阿司匹林)片剂在最初24小时内具有高阻性且无刺激电位,之后崩解并直接接触组织。Procardia XL缓释片具有不溶性外壳,即使在48小时后仍继续泄漏组织刺激性内容,产生长时间的阻塞性和刺激性状况。总之,缓释药物大大增加了食管损伤的风险。它们的阻滞电位和组织刺激电位差别很大。缓释制剂应禁用于患有食管和胃梗阻性疾病的患者。
{"title":"Increased risk in esophageal obstruction with slow-release medications.","authors":"V Simko,&nbsp;D Joseph,&nbsp;S Michael","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although medication-induced (pill) esophagitis has been recognized for a long time, little data are available on the risk of recently introduced slow-release medications. These formulations may have an obstructive capability (undissolved medication blocking an obstructed lumen) or may cause tissue irritation (continuous leakage from a slowly disintegrating pill). We observed a patient with esophageal carcinoma who developed complete obstruction when three Procardia XL (nifedipine) extended-release tablets blocked the narrowed lumen. An intact Procardia XL tablet and a washed shell as a control were implanted subcutaneously in a rat. The intact pill produced a large inflammatory mass: in contrast, no inflammatory response was noted at the control site implanted with a washed shell. In vitro testing of seven different slow-release medications revealed a wide difference in their solubility at a neutral pH and in gastric juice of pH 1.8 (simulation of esophageal or gastric environment). Theolair-SR (anhydrous theophylline, sustained-release) tablets had the highest obstructive, but no irritating potential. Cardizem SR (diltiazem hydrochloride) sustained-release capsules dissolved promptly without obstructive potential. Adalat CC (nifedipine) extended-release tablets also dissolved early at both pH values. Cardizem CD (diltiazem hydrochloride) extended-release capsules and Calan SR (verapamil hydrochloride) sustained-release oral caplets disintegrated into granules that had a low obstructive potential, but their prolonged presence increased the risk of tissue irritation. Ecotrin (enteric-coated aspirin) tablets had a high obstructive and no irritating potential in the first 24 hours, after which they disintegrated and directly contacted the tissue. Procardia XL extended-release tablets had an insoluble shell that continued to leak a tissue-irritating content even after 48 hours, generating a prolonged obstructive and irritating condition. In conclusion, slow-release medications greatly increase the risk of esophageal injury. Their obstructive and tissue-irritating potentials differ widely. Slow-release formulations should be contraindicated in patients who have obstructive esophageal and gastric disorders.</p>","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20114376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting cancer issues in African Americans. 重新审视非裔美国人的癌症问题。
C R Baquet
{"title":"Revisiting cancer issues in African Americans.","authors":"C R Baquet","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77227,"journal":{"name":"Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20114369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1